NFKB1 and neoplasm: Doxorubicin and NF-κB inhibitor PDTC entrapped folic acid conjugated chitosan nanoparticles enhanced intracellular targeting of tumor cells via folic acid receptor mediated endocytosis and lowered IC50 values compared to free drug to overcome resistance (Fan et al., 2010).